BIOGRAPHICAL SKETCH
NAME
POSITION TITLE
Athanassios Vratimos
Post-doctoral research associate
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)
INSTITUTION AND LOCATION
DEGREE
(if pplicable)
YEAR(s)
FIELD OF STUDY
Bachelor of Science in Biomedical Science
(Biochemistry & Genetics), the University of Sheffied,
UK
BSc
9/1996 - 6/1999
Molecular Biology
PhD in Molecular Biology, the University of Sheffield,
UK
PhD
11/1999 – 6/2003
Molecular Biology
Post-doctoral research in Molecular Immunology,
Queen Mary, the University of London
2003-2004
Molecular Immunology
Post-doctoral research & project management in
Genomics, the University of Nottingham & MARS Inc.
2004-2006
Genomics
Post-doctoral research in Cancer Genetics, NCSR
Demokritos
2012-current
Cancer Genetics
A. Peer-reviewed publications (in chronological order). Do not include publications
submitted or in preparation.
1. Hunter MJ, Vratimos A, Helm BA. “Generation of canine - Human Fc IgE chimeric antibodies for the
determination of the canine IgE domain of interaction with FcRI.” Molecular Immunology 2008, Vol 45,
2262-2268.
2. Pejnovic N, Vratimos A, Lee, SH, Popadic D, Takeda K, Akira S, Chan WL. “Increased
atherosclerotic lesions and Th17 cells in Interleukin-18 deficient apolipoprotein E-knockout mice fed with
high cholesterol diet.” Molecular Immunology 2009, Vol 47 (1), 37-45.
3. Pazaitou K, Giatzakis C, Koutsodontis G, Vratimos A, Chrisoulidou A, Konstantinidis T, Kamakari S.
“Identification of two novel mutations in the RET proto-oncogene in the same family.” Thyroid 2010, Vol
20 (4), 401-406.
4. Rashid A, Sadroddiny E, Ye HT, Vratimos A, Sabban S, Carey E, Helm B. “Diagnostic and
therapeutic applications of rat basophilic leukemia cells.” Molecular Immunology 2012, Vol 52 (3-4), 2248.
5. Sabban, S.+, Ye, H.+, Vratimos, A.+, Moir, A.J.G., Wheeler, A. Helm, B.A. “ Towards a pan-anti-allergy
vaccine.” Journal of Immune Based Therapies, Vaccines and Antimicrobials 2013, Vol 2, 15-27.
Komen for the Cure 2007
(PHS 398/2590 May be used)
Page
1
Biographical Sketch Format Page
Principal Investigator/Program Director (Last, First, Middle):
PI Name
6. Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, Carpenter J, ChangClaude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper WJ, Rafiq
S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Apostolou P, Konstanta I, Kotoula V,
Lakis S, Dimopoulos MA, Skarlos D, Pectasides D, Fountzilas G, Beckmann MW, Hein A, Ruebner M,
Ekici AB, Hartmann A, Schulz-Wendtland R, Renner SP, Janni W, Rack B, Scholz C, Neugebauer J,
Andergassen U, Lux MP, Haeberle L, Clarke C, Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels
S, Olson JE, Ingle JN, Olswold C, Slettedahl S, Eckel-Passow JE, Anderson SK, Visscher DW, Cafourek
V, Sicotte H, Prodduturi N, Weiderpass E, Bernstein L, Ziogas A, Ivanovich J, Giles GG, Baglietto L,
Southey M, Kosma VM, Fischer HP, Network TG, Reed MW, Cross SS, Deming-Halverson S, Shrubsole
M, Cai Q, Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, Rüdiger T, Wölfing H,
Ulmer HU, Försti A, Khoury T, Kumar S, Pilarski R, Shapiro CL, Greco D, Heikkilä P, Aittomäki K,
Blomqvist C, Irwanto A, Liu J, Pankratz VS, Wang X, Severi G, Mannermaa A, Easton D, Hall P, Brauch
H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H, Vachon CM,
Couch FJ. “Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk
factors for triple negative breast cancer.” Carcinogenesis 2013, Dec 9.
7. Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles
RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, Spurdle
AB, Walker LC, Lose F, Maia AT, Montagna M, Matricardi L, Lubinski J, Jakubowska A, Gomez-Garcia
EB, Olopade OI, Nussbaum RL, Nathanson KL, Domchek SM, Rebbeck TR, Arun BK, Karlan BY,
Orsulic S, Lester J, Chung WK, Miron A, Southey MC, Goldgar DE, Buys SS, Janavicius R, Dorfling CM,
van Rensburg EJ, Ding YC, Neuhausen SL, Hansen TV, Gerdes AM, Ejlertsen B, Jønson L, Osorio A,
Martinez-Bouzas C, Benitez J, Conway EE, Blazer KR, Weitzel JN, Manoukian S, Peissel B, Zaffaroni D,
Scuvera G, Barile M, Ficarazzi F, Mariette F, Fortuzzi S, Viel A, Giannini G, Papi L, Martayan A, Tibiletti
MG, Radice P, Vratimos A, Fostira F, Garber JE, Donaldson A, Brewer C, Foo C, Evans DG, Frost D,
Eccles D, Brady A, Cook J, Tischkowitz M, Adlard J, Barwell J, Walker L, Izatt L, Side LE, Kennedy MJ,
Rogers MT, Porteous ME, Morrison PJ, Platte R, Davidson R, Hodgson SV, Ellis S, Cole T, Godwin AK,
Claes K, Van Maerken T, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Plendl
H, Kast K, Rhiem K, Ditsch N, Arnold N, Varon-Mateeva R, Wappenschmidt B, Wang-Gohrke S,
Bressac-de Paillerets B, Buecher B, Delnatte C, Houdayer C, Stoppa-Lyonnet D, Damiola F, Coupier I,
Barjhoux L, Venat-Bouvet L, Golmard L, Boutry-Kryza N, Sinilnikova OM, Caron O, Pujol P, Mazoyer S,
Belotti M, Piedmonte M, Friedlander ML, Rodriguez GC, Copeland LJ, de la Hoya M, Perez Segura P,
Nevanlinna H, Aittomäki K, van Os TA, Meijers-Heijboer HE, Van der Hout AH, Vreeswijk MP,
Hoogerbrugge N, Ausems MG, Van Doorn HC, Collée JM, Olah E, Díez O, Blanco I, Lazaro C, Brunet J,
Feliubadaló L, Cybulski C, Gronwald J, Durda K, Jaworska-Bieniek K, Sukiennicki G, Arason A,
Chiquette J, Teixeira MR, Olswold C, Couch FJ, Lindor NM, Wang X, Szabo CI, Offit K, Corines M,
Jacobs L, Robson M, Zhang L, Joseph V, Berger A, Singer CF, Rappaport C, Geschwantler Kaulich D,
Pfeiler G, Tea MK, Phelan CM, Greene MH, Mai PL, Rennert G, Mulligan AM, Glendon G, Tchatchou S,
Andrulis IL, Toland AE, Bojesen A, Pedersen IS, Thomassen M, Jensen UB, Laitman Y, Rantala J, von
Wachenfeldt A, Ehrencrona H, Stenmark Askmalm M, Borg A, Kuchenbaecker KB, McGuffog L,
Barrowdale D, Healey S, Lee A, Pharoah PD, Chenevix-Trench G On Behalf Of Aocs Mamagement
Group, Antoniou AC, Friedman E. Candidate genetic modifiers for breast and ovarian cancer risk in
BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2014, Oct 21
8. Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Olson JE, Godwin AK, Pankratz VS,
Olswold C, Slettedahl S, Hallberg E, Guidugli L, Davila JI, Beckmann MW, Janni W, Rack B, Ekici AB,
Slamon DJ, Konstantopoulou I, Fostira F, Vratimos A, Fountzilas G, Pelttari LM, Tapper WJ, Durcan L,
Cross SS, Pilarski R, Shapiro CL, Klemp J, Yao S, Garber J, Cox A, Brauch H, Ambrosone C,
Nevanlinna H, Yannoukakos D, Slager SL, Vachon CM, Eccles DM, Fasching PA. Inherited Mutations in
17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort
Unselected for Family History of Breast Cancer. J Clin Oncol. 2014 Dec 1
9. Apostolou, P.; Vratimos, A.; and Fostira F. (January 2015) Breast Cancer Susceptibility Genes. In:
eLS. John Wiley & Sons, Ltd: Chichester. DOI: 10.1001/9780470015902.a0025847
PHS 398/2590 (Rev. 09/04, Reissued 4/2006)
Page
2
Continuation Format Page